Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 782,998 | 2,958,611 | 2,677,950 | 1,581,334 | 777,483 |
| Depreciation Amortization | 581,689 | 2,599,957 | 1,622,433 | 1,055,736 | 498,306 |
| Accounts receivable | -307,815 | -187,812 | -523,667 | -426,835 | -312,890 |
| Accounts payable and accrued liabilities | 99,484 | 82,592 | 94,681 | 43,138 | 14,749 |
| Other Working Capital | -361,654 | -920,960 | -1,023,956 | -1,373,592 | -701,631 |
| Other Operating Activity | 162,686 | -83,723 | 239,624 | 395,050 | 309,729 |
| Operating Cash Flow | $957,387 | $4,448,665 | $3,087,065 | $1,274,830 | $585,746 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -519,658 | -1,764,984 | -1,348,911 | -885,456 | -507,787 |
| Net Acquisitions | -57,350 | N/A | -3,413,188 | -3,406 | N/A |
| Purchase Of Investment | -676,491 | -1,819,291 | -1,375,795 | N/A | -347,655 |
| Sale Of Investment | 436,559 | N/A | N/A | N/A | 449,845 |
| Purchase Sale Intangibles | -66,713 | -228,543 | -123,903 | -198,660 | -36,873 |
| Other Investing Activity | -66,713 | -1,236,621 | 1,838,680 | 250,879 | -35,819 |
| Investing Cash Flow | $-883,652 | $-4,820,896 | $-4,299,214 | $-637,982 | $-441,417 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -8,064,619 | 945,640 | 918,377 | N/A |
| Debt Repayment | -56,179 | 9,961,977 | 1,260,074 | -1,846,970 | -1,646,620 |
| Dividend Paid | N/A | -332,632 | -343,657 | -332,614 | N/A |
| Other Financing Activity | -16,386 | -854,207 | -882,519 | -857,076 | -48,462 |
| Financing Cash Flow | $-72,565 | $710,519 | $979,538 | $-2,118,283 | $-1,695,082 |
| Exchange Rate Effect | 3,511 | -87,118 | -78,316 | -51,084 | -42,140 |
| Beginning Cash Position | 3,206,896 | 2,847,734 | 2,942,121 | 2,857,298 | 2,651,659 |
| End Cash Position | 3,210,407 | 3,100,036 | 2,631,194 | 1,323,643 | 1,058,767 |
| Net Cash Flow | $3,511 | $252,302 | $-310,927 | $-1,533,655 | $-1,592,892 |
| Free Cash Flow | |||||
| Operating Cash Flow | 957,387 | 4,448,665 | 3,087,065 | 1,274,830 | 585,746 |
| Capital Expenditure | -530,191 | -1,793,269 | -1,361,769 | -893,402 | -513,055 |
| Free Cash Flow | 427,196 | 2,655,396 | 1,725,296 | 381,428 | 72,692 |